EVOLUS, INC. Increase (Decrease) in Accounts Payable
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Accounts Payable of -$4.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- EVOLUS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.63M.
- EVOLUS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$7.61M, a 261.14% decline year-over-year.
- EVOLUS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.05M.
- EVOLUS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $4.11M, a 16.62% increase year-over-year.
- EVOLUS, INC. increase (decrease) in accounts payable for fiscal 2025 was $10.10M, a 2483.89% increase from fiscal 2024.
- EVOLUS, INC. increase (decrease) in accounts payable for fiscal 2024 was $391.00K.
- EVOLUS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$1.02M, a 205.06% decline from fiscal 2022.
- EVOLUS, INC. increase (decrease) in accounts payable for fiscal 2022 was $968.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.98M 10-Q · filed 2026-08-05 | -$2.93M derived: sum of 3 quarters · filed 2026-08-05 | $1.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$7.61M 10-Q · filed 2026-05-04 | -$5.56M derived: sum of 2 quarters · filed 2026-05-04 | -$1.45M derived: sum of 3 quarters · filed 2026-05-04 | -$2.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.16M derived: sum of 2 quarters · filed 2026-03-03 | $5.38M derived: sum of 3 quarters · filed 2026-08-05 | $10.10M 10-K · filed 2026-03-03 |
| 2025-09-30 | $4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.33M derived: sum of 2 quarters · filed 2026-08-05 | $8.06M 10-Q · filed 2025-11-05 | $5.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$777.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.94M 10-Q · filed 2026-08-05 | $1.06M derived: sum of 3 quarters · filed 2026-08-05 | $4.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $4.72M 10-Q · filed 2026-05-04 | $1.83M derived: sum of 2 quarters · filed 2026-05-04 | $5.36M derived: sum of 3 quarters · filed 2026-05-04 | $4.20M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $637.00K derived: sum of 2 quarters · filed 2026-03-03 | -$518.00K derived: sum of 3 quarters · filed 2026-03-03 | $391.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.37M derived: sum of 2 quarters · filed 2025-11-05 | $3.28M 10-Q · filed 2025-11-05 | -$2.53M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$246.00K 10-Q · filed 2025-08-05 | -$6.05M derived: sum of 3 quarters · filed 2026-03-03 | -$4.69M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $909.00K 10-Q · filed 2025-05-07 | -$4.90M derived: sum of 2 quarters · filed 2026-03-03 | -$3.53M derived: sum of 3 quarters · filed 2026-03-03 | -$3.25M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$4.44M derived: sum of 2 quarters · filed 2026-03-03 | -$4.16M derived: sum of 3 quarters · filed 2026-03-03 | -$1.02M 10-K · filed 2026-03-03 |
| 2023-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.65M derived: sum of 2 quarters · filed 2024-11-06 | $4.79M 10-Q · filed 2024-11-06 | $3.42M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $3.42M 10-Q · filed 2024-07-31 | $2.06M derived: sum of 3 quarters · filed 2025-03-04 | -$1.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $3.14M 10-Q · filed 2024-05-07 | $1.77M derived: sum of 2 quarters · filed 2025-03-04 | -$284.00K derived: sum of 3 quarters · filed 2025-03-04 | $2.64M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$3.43M derived: sum of 2 quarters · filed 2025-03-04 | -$503.00K derived: sum of 3 quarters · filed 2025-03-04 | $968.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $867.00K derived: sum of 2 quarters · filed 2023-11-07 | $2.34M 10-Q · filed 2023-11-07 | $3.86M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $4.39M 10-Q · filed 2023-08-02 | $5.92M derived: sum of 3 quarters · filed 2023-08-02 | $5.16M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $1.47M 10-Q · filed 2023-05-09 | $3.00M derived: sum of 2 quarters · filed 2023-05-09 | $2.23M derived: sum of 3 quarters · filed 2023-05-09 | $2.49M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $762.00K derived: sum of 2 quarters · filed 2023-03-08 | $1.02M derived: sum of 3 quarters · filed 2023-03-08 | -$787.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$763.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$504.00K derived: sum of 2 quarters · filed 2022-11-08 | -$2.31M 10-Q · filed 2022-11-08 | $2.85M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$1.55M 10-Q · filed 2022-08-02 | $3.62M derived: sum of 3 quarters · filed 2022-08-02 | $7.35M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$1.81M 10-Q · filed 2022-05-10 | $3.36M derived: sum of 2 quarters · filed 2022-05-10 | $7.09M derived: sum of 3 quarters · filed 2022-05-10 | $180.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $8.89M derived: sum of 2 quarters · filed 2022-03-03 | $1.99M derived: sum of 3 quarters · filed 2022-03-03 | $2.32M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$3.18M derived: sum of 2 quarters · filed 2021-11-02 | -$2.85M 10-Q · filed 2021-11-02 | -$3.40M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$6.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$6.58M 10-Q · filed 2021-08-04 | -$7.13M derived: sum of 3 quarters · filed 2021-08-04 | |
| 2020-03-31 | $332.00K 10-Q · filed 2021-05-12 | -$221.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | -$553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $183.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $736.00K 10-Q · filed 2020-10-29 | |||
| 2019-03-31 | $305.00K 10-Q · filed 2020-05-11 | $1.20M derived: sum of 2 quarters · filed 2020-05-11 | $1.11M derived: sum of 3 quarters · filed 2020-05-11 | $1.38M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $804.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.07M derived: sum of 3 quarters · filed 2020-02-25 | $1.27M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $173.00K derived: sum of 2 quarters · filed 2019-11-04 | $378.00K 10-Q · filed 2019-11-04 | $500.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $471.00K 10-Q · filed 2018-08-02 | $593.00K derived: sum of 3 quarters · filed 2019-05-01 | $385.00K derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-03-31 | $205.00K 10-Q · filed 2019-05-01 | $327.00K derived: sum of 2 quarters · filed 2019-05-01 | $119.00K derived: sum of 3 quarters · filed 2019-05-01 | -$236.00K derived: sum of 4 quarters · filed 2019-05-01 |
| 2017-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | -$86.00K derived: sum of 2 quarters · filed 2019-03-20 | -$441.00K derived: sum of 3 quarters · filed 2019-03-20 | -$2.43M 10-K · filed 2019-03-20 |
| 2017-09-30 | -$208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$563.00K derived: sum of 2 quarters · filed 2018-11-05 | -$2.55M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | -$355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$2.35M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$1.99M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |